Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Spa Societa Prodotti Antibiotici S.p.a.

Alfasigma S.p.a.

Maria Giovanna Caccia

Claudio Cavazza

The main object here is the use of omega-3 polyunsaturated fatty acids (as ethyl esters, hereinafter called 'n-3 PUFA') as a medicament, either alone or in combination with other therapeutic agents, for reducing mortality for a cardiovascular cause, in particular arrhythmia or for reducing hospitalization for any cause, in particular a cardiovascular cause and for the daily administration to patients with symptomatic heart failure (HF) for more than 3.5 years.

Growing community of inventors

Rovellasca, Italy

Maria Giovanna Caccia